当前位置：
X-MOL 学术
›
Ann. Intern. Med.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
In older adults, cannabinoid-based medicines increase adverse events compared with placebo
Annals of Internal Medicine ( IF 39.2 ) Pub Date : 2021-09-07 , DOI: 10.7326/acpj202109210-103 Jennifer Watt 1
中文翻译：
在老年人中，与安慰剂相比，基于大麻素的药物会增加不良事件
更新日期：2021-09-07
Annals of Internal Medicine ( IF 39.2 ) Pub Date : 2021-09-07 , DOI: 10.7326/acpj202109210-103 Jennifer Watt 1
Affiliation
Source Citation
Velayudhan L, McGoohan K, Bhattacharyya S. Safety and tolerability of natural and synthetic cannabinoids in adults aged over 50 years: a systematic review and meta-analysis. PLoS Med. 2021;18:e1003524. https://pubmed.ncbi.nlm.nih.gov/33780450
Clinical Impact Ratings
GIM/FP/GP: 
中文翻译：
在老年人中，与安慰剂相比，基于大麻素的药物会增加不良事件
来源引用
Velayudhan L、McGoohan K、Bhattacharyya S. 50 岁以上成人天然和合成大麻素的安全性和耐受性：系统评价和荟萃分析。公共科学图书馆医学。2021；18：e1003524。https://pubmed.ncbi.nlm.nih.gov/33780450
临床影响评级
GIM/FP/GP：
京公网安备 11010802027423号